14Dec
Covid–19 coronavirus: global merger review (UPDATED)
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid 19. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal practice, many cases may face changes in approach and practice (eg extensions of timelines in certain circumstances). The table below reflects our understanding of the current effects on the merger review process in numerous jurisdictions around the world. It...
By:
Allen & Overy LLP
Related
The US Food and Drug Administration (FDA or the Agency) on June 11 issued the final guidance: “Prem...
Read More >
Ending a more than 15-year-long legal battle, the Fifth Circuit on May 24, 2019, unanimously affirme...
Read More >
Many companies are taking precautions in light of the Corona Virus Disease 2019 (the Coronavirus or ...
Read More >
Litigators are familiar with the attorney-client privilege as the focus of many discovery disputes, ...
Read More >
On June 10, 2019, the U.S. Supreme Court agreed to hear Intel Corp. Investment Policy Committee et a...
Read More >
If so, you should be on alert about California Assembly Bill 5 (AB5), a bill based on the California...
Read More >